Ravi Subbiah

Bachelor's Degree: University of Mysore India, 1961 (Chemistry, Biology)

Master's Degree: University of Baroda India, 1964 (Clinical Biochemistry)

Doctoral Degree: University of Toronto Canada, 1970 (Biochemistry)

Mayo Clinic Rochester, MN, 1971 (Steroids, Atherosclerosis )

• Targeted Estrogen Therapy in Menopause
• Nutrigenomics and Nutraceutical Development

1971 -1973 Research Associate, Physiology, Mayo Clinic & Foundation, Rochester, MN

1973 -1974 Associate Consultant, Internal Medicine, Mayo Clinic & Foundation, Rochester, MN

1974 -1978 Consultant, Internal Medicine, Mayo Clinic & Foundation, Rochester, MN

1975 -1978 Assistant Professor, Biochemestry Internal Medicine, Mayo Graduate School, Rochester, MN

1978 -1981 Associate Professor, Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH

1981 -To Present Professor, Internal Medicine & Pathology, University of Cincinnati Medical Center, Cincinnati, OH

1985 - Visiting Scientist, Cambridge University, Cambridge, England

1978 -2006 Director, Lipid Laboratory, University of Cincinnati Medical Center, Cincinnati, OH

1980 -1991 Director, NIH Nutrition-Atherosclerosis Training Program, University of Cincinnati, Cincinnati, OH

1991 - Visiting Scientist, Unviersity of Salford, Salford, England

2000 -2007 Laboratory Director & Vice President, Molecular Diagnostics Laboratories, Inc, BioStart, Cincinnati, OH

2008 -To Present Professor & Associate Director, Office of Laboratory Resources & Regulations, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH

Grant: #DURAMED-05-01-A0-S0-E0 Investigators:Subbiah, M T Ravi 12-01-2000 -10-31-2002 Duramed Pharmaceuticals, Inc. Comparative Effect of Four Conjugated Estrogen Preparations on Oxidative Stress and Selected Endothelial Functional Parameters Role:PI $37,500.00 Closed Level:Industry

Grant: #1-R47-HL-68492-01-A1-S0-E0 Investigators:Subbiah, M T Ravi 09-30-2002 -09-29-2004 National Heart, Lung and Blood Institute Targeted Delivery of Estrogens in Menopause Role:PI $60,000.00 Closed Level:Federal

Grant: #5-R01-HL-50881-05-A0-S0-E0 Investigators:Subbiah, M T Ravi 09-30-1993 -08-31-1999 National Heart, Lung and Blood Institute Antioxidant Potential of Estrogens in Menopause Role:PI $833,242.00 Closed Level:Federal

Peer Reviewed Publications

Subbiah, M T Ravi (2010. ) Application of nutrigenomics in skin health: nutraceutical or cosmeceutical? .The Journal of clinical and aesthetic dermatology, , 3 (11 ) ,44-6

Subbiah, M T Ravi (2008. ) Understanding the nutrigenomic definitions and concepts at the food-genome junction.Omics : a journal of integrative biology, , 12 (4 ) ,229-35 More Information

Subbiah, M T Ravi; Yunker, R (2008. ) Studies on the nature of anti-platelet aggregatory factors in the seeds of the Amazonian Herb Guarana (Paullinia cupana).International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition, , 78 (2 ) ,96-101 More Information

Subbiah, M T Ravi (2007. ) Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine.Translational research : the journal of laboratory and clinical medicine, , 149 (2 ) ,55-61 More Information

Subbiah, M T Ravi (2004. ) Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials.Atherosclerosis, , 173 (2 ) ,373-4 More Information

Subbiah, M T Ravi; Abplanalp, W (2003. ) Ergosterol (major sterol of baker's and brewer's yeast extracts) inhibits the growth of human breast cancer cells in vitro and the potential role of its oxidation products. International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition, , 73 (1 ) ,19-23

Subbiah, M T Ravi (2003. ) Long term-effects of hormone replacement therapy. Lancet, , 361 (9353 ) ,255

Subbiah, M T Ravi; Abplanalp, William (2002. ) Evidence of increased formation of products retaining strong antioxidant activity from estradiol-17beta oxidation in the presence of human plasma lipoproteins. The Journal of laboratory and clinical medicine, , 139 (6 ) ,357-63

1976 Visiting Scientist Unilever Research Labs, Vlaardingen, Holland

1985 Burroughs-Welcome Travel Award Cambridge University, England

1991 Burroughs-Welcome Travel Award University of Salford, England

Transdermal Drug Delivery(MeSH TrDrgDel),Cardiovascular Diseases(MeSH C14),Nutritional and Metabolic Diseases(MeSH C18),Hormones, Hormone Substitutes, and Hormone Antagonists(MeSH D06),Therapeutics(MeSH E02),Biochemical Phenomena, Metabolism, and Nutrition(MeSH G06),Chemical and Pharmacologic Phenomena(MeSH G12)